Title : Troglitazone.

Pub. Date : 1997 Jul

PMID : 9211083






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Troglitazone decreases insulin resistance (improves insulin sensitivity), which results in reduced plasma glucose and insulin levels in patients with non-insulin-dependent diabetes mellitus (NIDDM). Troglitazone insulin Homo sapiens
2 Troglitazone decreases insulin resistance (improves insulin sensitivity), which results in reduced plasma glucose and insulin levels in patients with non-insulin-dependent diabetes mellitus (NIDDM). Troglitazone insulin Homo sapiens
3 Risk factors for cardiovascular disease such as elevated proinsulin and triglyceride levels are also reduced by troglitazone. Troglitazone insulin Homo sapiens
4 In clinical trials, troglitazone 200 to 800 mg daily (alone or in combination with other oral antidiabetic agents or insulin) reduced plasma or serum glucose levels and glycosylated haemoglobin compared with both baseline and placebo in patients with NIDDM refractory to other oral antidiabetic agents (usually sulphonylureas). Troglitazone insulin Homo sapiens